Bill Detail
S. 1097
Congress: 119
Title
Interagency Patent Coordination and Improvement Act of 2025
Summary
Interagency Patent Coordination and Improvement Act of 2025 This bill establishes the Interagency Task Force on Patents to support coordination and communication between the U.S. Patent and Trademark Office (USPTO) and the Food and Drug Administration (FDA) on activities relating to patents for human drugs and biological products. The task force's duties shall include sharing information about (1) the processes of each agency, including how each agency evaluates applications (e.g., patent applications at the USPTO and new drug applications at the FDA); and (2) new approvals of patents, human drugs, biological products, and new technologies. The task force must also establish a process that requires (1) the USPTO to request from the FDA information relating to certain patent applications to help patent examiners carry out their duties, (2) the FDA to provide such information to the USPTO, and (3) the USPTO to assist the FDA in its ministerial role of listing patents.
Sponsor
Sen. Richard Durbin [D-IL]
Status
Placed on Senate Legislative Calendar under General Orders. Calendar No. 41.
Status as of Aug 14, 12:20 PM · synced 6h ago
Introduced
2025-03-24
Data source mode: cache
Bill Engagement
Interagency Patent Coordination and Improvement Act of 2025 This bill establishes the Interagency Task Force on Patents to support coordination and communication between the U.S…
Lobbyists on the case
- Pharmaceutical Research and Manufacturers of America5 filings · 19 lobs
Prepared intelligence brief
Put this record in the joined picture.
Unlock every organization and lobbyist filing on this bill, the complete event and issue map, private team positions, and recurring movement alerts across the portfolio.